Professor Colin Cooper
Bob Champion Research and Education Building, Chair of Cancer Genetics at the University of East Anglia.
"The Bob Champion Cancer Trust is monitoring the impact of the coronavirus SAR-CoV-2 that is causing the COVID-19 pandemic, and working with our scientists and clinicians to minimise disruption. Developments in Universities and Research Institute has made it increasingly difficult to continue both laboratory based research and clinical projects involving collecting samples from patients. For example, most research laboratories in the UK are now closed for all except for essential activities. This necessary pause is not impacting on bioinformatics research funding by the Bob Champion Cancer Trust, since this work only requires computers and can be carried out equally effectively at home. Our laboratory workers are also working from home but are focusing on analysing data and writing up research for publication. The clinicians that we fund are now on the frontline in the fight against COVID-19; we give them our thanks and wish them good health.
Over the past year the Bob Champion Cancer Trust has witnessed remarkable success in its funding with the development of novel biomarkers for detecting aggressive prostate cancer and in the application of cancer genetics to patient management. It is important that we now work together to ensure that we can support all of the research that will be necessary when the COVID-19 pandemic is over. We thank you all for your continued support."